Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 2
2013 1
2014 1
2015 2
2016 8
2017 9
2018 5
2019 5
2020 1
2021 9
2022 11
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Results by year
Filters applied: . Clear all
Page 1
COVID-19 vaccinations: The unknowns, challenges, and hopes.
Mohamed K, Rzymski P, Islam MS, Makuku R, Mushtaq A, Khan A, Ivanovska M, Makka SA, Hashem F, Marquez L, Cseprekal O, Filgueiras IS, Fonseca DLM, Mickael E, Ling I, Arero AG, Cuschieri S, Minakova K, Rodríguez-Román E, Abarikwu SO, Faten AB, Grancini G, Cabral-Marques O, Rezaei N. Mohamed K, et al. Among authors: cabral marques o. J Med Virol. 2022 Apr;94(4):1336-1349. doi: 10.1002/jmv.27487. Epub 2021 Dec 10. J Med Virol. 2022. PMID: 34845731 Free PMC article. Review.
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
Cabral-Marques O, Halpert G, Schimke LF, Ostrinski Y, Vojdani A, Baiocchi GC, Freire PP, Filgueiras IS, Zyskind I, Lattin MT, Tran F, Schreiber S, Marques AHC, Plaça DR, Fonseca DLM, Humrich JY, Müller A, Giil LM, Graßhoff H, Schumann A, Hackel A, Junker J, Meyer C, Ochs HD, Lavi YB, Scheibenbogen C, Dechend R, Jurisica I, Schulze-Forster K, Silverberg JI, Amital H, Zimmerman J, Heidecke H, Rosenberg AZ, Riemekasten G, Shoenfeld Y. Cabral-Marques O, et al. Nat Commun. 2022 Mar 9;13(1):1220. doi: 10.1038/s41467-022-28905-5. Nat Commun. 2022. PMID: 35264564 Free PMC article.
Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States.
Schimke LF, Marques AHC, Baiocchi GC, de Souza Prado CA, Fonseca DLM, Freire PP, Rodrigues Plaça D, Salerno Filgueiras I, Coelho Salgado R, Jansen-Marques G, Rocha Oliveira AE, Peron JPS, Cabral-Miranda G, Barbuto JAM, Camara NOS, Calich VLG, Ochs HD, Condino-Neto A, Overmyer KA, Coon JJ, Balnis J, Jaitovich A, Schulte-Schrepping J, Ulas T, Schultze JL, Nakaya HI, Jurisica I, Cabral-Marques O. Schimke LF, et al. Among authors: cabral marques o. Cells. 2022 Mar 1;11(5):847. doi: 10.3390/cells11050847. Cells. 2022. PMID: 35269470 Free PMC article.
Mechanisms of Autoantibody-Induced Pathology.
Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, Komorowski L, Luo J, Cabral-Marques O, Hammers CM, Lindstrom JM, Lamprecht P, Fischer A, Riemekasten G, Tersteeg C, Sondermann P, Rapoport B, Wandinger KP, Probst C, El Beidaq A, Schmidt E, Verkman A, Manz RA, Nimmerjahn F. Ludwig RJ, et al. Among authors: cabral marques o. Front Immunol. 2017 May 31;8:603. doi: 10.3389/fimmu.2017.00603. eCollection 2017. Front Immunol. 2017. PMID: 28620373 Free PMC article. Review.
Vaccines against Emerging and Neglected Infectious Diseases: An Overview.
Vuitika L, Prates-Syed WA, Silva JDQ, Crema KP, Côrtes N, Lira A, Lima JBM, Camara NOS, Schimke LF, Cabral-Marques O, Sadraeian M, Chaves LCS, Cabral-Miranda G. Vuitika L, et al. Among authors: cabral marques o. Vaccines (Basel). 2022 Aug 25;10(9):1385. doi: 10.3390/vaccines10091385. Vaccines (Basel). 2022. PMID: 36146463 Free PMC article. Review.
Loss of balance in normal GPCR-mediated cell trafficking.
Cabral-Marques O, Carvalho-Marques AH, Schimke LF, Heidecke H, Riemekasten G. Cabral-Marques O, et al. Front Biosci (Landmark Ed). 2019 Jan 1;24(1):18-34. doi: 10.2741/4707. Front Biosci (Landmark Ed). 2019. PMID: 30468645 Free article. Review.
CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives.
França TT, Barreiros LA, Al-Ramadi BK, Ochs HD, Cabral-Marques O, Condino-Neto A. França TT, et al. Among authors: cabral marques o. Expert Rev Clin Immunol. 2019 May;15(5):529-540. doi: 10.1080/1744666X.2019.1573674. Epub 2019 Feb 18. Expert Rev Clin Immunol. 2019. PMID: 30681380 Review.
The clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations.
Filgueiras IS, Torrentes de Carvalho A, Cunha DP, Mathias da Fonseca DL, El Khawanky N, Freire PP, Cabral-Miranda G, Schimke LF, Camara NOS, Ochs HD, Peron JPS, Cabral-Marques O, de Vasconcelos ZFM. Filgueiras IS, et al. Among authors: cabral marques o. PLoS Negl Trop Dis. 2021 Aug 5;15(8):e0009575. doi: 10.1371/journal.pntd.0009575. eCollection 2021 Aug. PLoS Negl Trop Dis. 2021. PMID: 34351896 Free PMC article. Review.
Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19.
Tran F, Harris DMM, Scharmacher A, Graßhoff H, Sterner K, Schinke S, Käding N, Humrich JY, Cabral-Marques O, Bernardes JP, Mishra N, Bahmer T, Franzenburg J, Hoyer BF, Glück A, Guggeis M, Ossysek A, Küller A, Frank D, Lange C, Rupp J, Heyckendorf J, Gaede KI, Amital H, Rosenstiel P, Shoenfeld Y, Halpert G, Rosenberg AZ, Schulze-Forster K, Heidecke H, Riemekasten G, Schreiber S. Tran F, et al. Among authors: cabral marques o. ERJ Open Res. 2022 Dec 27;8(4):00379-2022. doi: 10.1183/23120541.00379-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36575710 Free PMC article.
53 results